Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0005794 | Golgi apparatus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4H6N3
Term | Name | Level | Count |
---|---|---|---|
GO:0006497 | protein lipidation | 5 | 1 |
GO:0006605 | protein targeting | 5 | 1 |
GO:0006612 | protein targeting to membrane | 5 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0006810 | transport | 3 | 1 |
GO:0006886 | intracellular protein transport | 4 | 1 |
GO:0006897 | endocytosis | 5 | 1 |
GO:0008104 | protein localization | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0015031 | protein transport | 4 | 1 |
GO:0016192 | vesicle-mediated transport | 4 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018198 | peptidyl-cysteine modification | 6 | 1 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 7 | 1 |
GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 7 | 1 |
GO:0018345 | protein palmitoylation | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0033036 | macromolecule localization | 2 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043543 | protein acylation | 5 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045184 | establishment of protein localization | 3 | 1 |
GO:0046907 | intracellular transport | 3 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 1 |
GO:0051649 | establishment of localization in cell | 3 | 1 |
GO:0051668 | localization within membrane | 3 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 1 |
GO:0071702 | organic substance transport | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0071705 | nitrogen compound transport | 4 | 1 |
GO:0072657 | protein localization to membrane | 4 | 1 |
GO:0090150 | establishment of protein localization to membrane | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0016409 | palmitoyltransferase activity | 5 | 10 |
GO:0016417 | S-acyltransferase activity | 5 | 10 |
GO:0016740 | transferase activity | 2 | 10 |
GO:0016746 | acyltransferase activity | 3 | 10 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 10 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 4 | 10 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 3 | 10 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 10 | 14 | PF00656 | 0.663 |
CLV_C14_Caspase3-7 | 118 | 122 | PF00656 | 0.666 |
CLV_C14_Caspase3-7 | 179 | 183 | PF00656 | 0.661 |
CLV_NRD_NRD_1 | 199 | 201 | PF00675 | 0.492 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.418 |
CLV_NRD_NRD_1 | 301 | 303 | PF00675 | 0.426 |
CLV_PCSK_FUR_1 | 210 | 214 | PF00082 | 0.408 |
CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.471 |
CLV_PCSK_KEX2_1 | 199 | 201 | PF00082 | 0.497 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.429 |
CLV_PCSK_KEX2_1 | 301 | 303 | PF00082 | 0.435 |
CLV_PCSK_KEX2_1 | 420 | 422 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 438 | 440 | PF00082 | 0.361 |
CLV_PCSK_PC1ET2_1 | 127 | 129 | PF00082 | 0.471 |
CLV_PCSK_PC1ET2_1 | 420 | 422 | PF00082 | 0.502 |
CLV_PCSK_PC1ET2_1 | 438 | 440 | PF00082 | 0.361 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.503 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.628 |
DOC_CYCLIN_yCln2_LP_2 | 5 | 11 | PF00134 | 0.624 |
DOC_MAPK_MEF2A_6 | 378 | 386 | PF00069 | 0.321 |
DOC_PP2B_LxvP_1 | 157 | 160 | PF13499 | 0.677 |
DOC_PP4_FxxP_1 | 216 | 219 | PF00568 | 0.722 |
DOC_SPAK_OSR1_1 | 163 | 167 | PF12202 | 0.627 |
DOC_USP7_MATH_1 | 109 | 113 | PF00917 | 0.636 |
DOC_USP7_MATH_1 | 131 | 135 | PF00917 | 0.701 |
DOC_USP7_MATH_1 | 191 | 195 | PF00917 | 0.737 |
DOC_USP7_MATH_1 | 219 | 223 | PF00917 | 0.701 |
DOC_USP7_MATH_1 | 28 | 32 | PF00917 | 0.725 |
DOC_USP7_MATH_1 | 288 | 292 | PF00917 | 0.505 |
DOC_USP7_MATH_1 | 55 | 59 | PF00917 | 0.676 |
DOC_USP7_MATH_1 | 95 | 99 | PF00917 | 0.662 |
DOC_USP7_UBL2_3 | 123 | 127 | PF12436 | 0.664 |
DOC_USP7_UBL2_3 | 312 | 316 | PF12436 | 0.635 |
DOC_USP7_UBL2_3 | 431 | 435 | PF12436 | 0.538 |
DOC_WW_Pin1_4 | 11 | 16 | PF00397 | 0.703 |
DOC_WW_Pin1_4 | 29 | 34 | PF00397 | 0.723 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.738 |
DOC_WW_Pin1_4 | 88 | 93 | PF00397 | 0.656 |
LIG_14-3-3_CanoR_1 | 218 | 224 | PF00244 | 0.637 |
LIG_14-3-3_CanoR_1 | 334 | 340 | PF00244 | 0.440 |
LIG_Actin_WH2_2 | 396 | 412 | PF00022 | 0.369 |
LIG_BIR_III_4 | 121 | 125 | PF00653 | 0.661 |
LIG_BRCT_BRCA1_1 | 160 | 164 | PF00533 | 0.619 |
LIG_BRCT_BRCA1_1 | 239 | 243 | PF00533 | 0.529 |
LIG_eIF4E_1 | 276 | 282 | PF01652 | 0.359 |
LIG_FHA_1 | 270 | 276 | PF00498 | 0.347 |
LIG_FHA_1 | 291 | 297 | PF00498 | 0.474 |
LIG_FHA_1 | 422 | 428 | PF00498 | 0.595 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.647 |
LIG_Integrin_RGD_1 | 50 | 52 | PF01839 | 0.451 |
LIG_LIR_Apic_2 | 31 | 37 | PF02991 | 0.654 |
LIG_LIR_Gen_1 | 244 | 250 | PF02991 | 0.241 |
LIG_LIR_Gen_1 | 263 | 273 | PF02991 | 0.242 |
LIG_LIR_Gen_1 | 338 | 349 | PF02991 | 0.456 |
LIG_LIR_Gen_1 | 350 | 359 | PF02991 | 0.295 |
LIG_LIR_Gen_1 | 411 | 418 | PF02991 | 0.590 |
LIG_LIR_Gen_1 | 422 | 433 | PF02991 | 0.542 |
LIG_LIR_Nem_3 | 240 | 246 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 263 | 269 | PF02991 | 0.279 |
LIG_LIR_Nem_3 | 338 | 344 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 350 | 355 | PF02991 | 0.307 |
LIG_LIR_Nem_3 | 422 | 428 | PF02991 | 0.549 |
LIG_PDZ_Class_2 | 438 | 443 | PF00595 | 0.571 |
LIG_Pex14_1 | 239 | 243 | PF04695 | 0.529 |
LIG_SH2_CRK | 230 | 234 | PF00017 | 0.362 |
LIG_SH2_CRK | 276 | 280 | PF00017 | 0.399 |
LIG_SH2_CRK | 34 | 38 | PF00017 | 0.657 |
LIG_SH2_PTP2 | 246 | 249 | PF00017 | 0.529 |
LIG_SH2_SRC | 223 | 226 | PF00017 | 0.521 |
LIG_SH2_STAP1 | 337 | 341 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 246 | 249 | PF00017 | 0.393 |
LIG_SH2_STAT5 | 250 | 253 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 337 | 340 | PF00017 | 0.521 |
LIG_SH2_STAT5 | 376 | 379 | PF00017 | 0.350 |
LIG_SH2_STAT5 | 397 | 400 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 404 | 407 | PF00017 | 0.625 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.706 |
LIG_SUMO_SIM_anti_2 | 278 | 283 | PF11976 | 0.393 |
LIG_SUMO_SIM_par_1 | 278 | 283 | PF11976 | 0.393 |
LIG_SUMO_SIM_par_1 | 78 | 84 | PF11976 | 0.664 |
LIG_WRC_WIRS_1 | 261 | 266 | PF05994 | 0.279 |
LIG_WRC_WIRS_1 | 281 | 286 | PF05994 | 0.367 |
MOD_CDC14_SPxK_1 | 36 | 39 | PF00782 | 0.653 |
MOD_CDK_SPxK_1 | 33 | 39 | PF00069 | 0.653 |
MOD_CK1_1 | 241 | 247 | PF00069 | 0.239 |
MOD_CK2_1 | 133 | 139 | PF00069 | 0.657 |
MOD_CK2_1 | 4 | 10 | PF00069 | 0.630 |
MOD_CK2_1 | 65 | 71 | PF00069 | 0.738 |
MOD_CK2_1 | 88 | 94 | PF00069 | 0.672 |
MOD_Cter_Amidation | 418 | 421 | PF01082 | 0.384 |
MOD_GlcNHglycan | 129 | 134 | PF01048 | 0.556 |
MOD_GlcNHglycan | 144 | 147 | PF01048 | 0.474 |
MOD_GlcNHglycan | 243 | 246 | PF01048 | 0.239 |
MOD_GlcNHglycan | 344 | 347 | PF01048 | 0.529 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.469 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.475 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.647 |
MOD_GSK3_1 | 202 | 209 | PF00069 | 0.740 |
MOD_GSK3_1 | 237 | 244 | PF00069 | 0.239 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.664 |
MOD_GSK3_1 | 301 | 308 | PF00069 | 0.635 |
MOD_GSK3_1 | 347 | 354 | PF00069 | 0.350 |
MOD_N-GLC_1 | 335 | 340 | PF02516 | 0.228 |
MOD_N-GLC_2 | 315 | 317 | PF02516 | 0.435 |
MOD_N-GLC_2 | 329 | 331 | PF02516 | 0.270 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.655 |
MOD_NEK2_1 | 142 | 147 | PF00069 | 0.766 |
MOD_NEK2_1 | 237 | 242 | PF00069 | 0.529 |
MOD_NEK2_1 | 269 | 274 | PF00069 | 0.422 |
MOD_NEK2_1 | 275 | 280 | PF00069 | 0.473 |
MOD_NEK2_1 | 409 | 414 | PF00069 | 0.584 |
MOD_PIKK_1 | 248 | 254 | PF00454 | 0.622 |
MOD_PIKK_1 | 433 | 439 | PF00454 | 0.556 |
MOD_PKA_1 | 301 | 307 | PF00069 | 0.635 |
MOD_PKA_2 | 206 | 212 | PF00069 | 0.756 |
MOD_PKA_2 | 301 | 307 | PF00069 | 0.635 |
MOD_Plk_1 | 335 | 341 | PF00069 | 0.428 |
MOD_Plk_1 | 421 | 427 | PF00069 | 0.593 |
MOD_Plk_4 | 238 | 244 | PF00069 | 0.529 |
MOD_Plk_4 | 269 | 275 | PF00069 | 0.454 |
MOD_Plk_4 | 335 | 341 | PF00069 | 0.494 |
MOD_Plk_4 | 354 | 360 | PF00069 | 0.393 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.701 |
MOD_ProDKin_1 | 11 | 17 | PF00069 | 0.701 |
MOD_ProDKin_1 | 29 | 35 | PF00069 | 0.724 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.739 |
MOD_ProDKin_1 | 88 | 94 | PF00069 | 0.655 |
TRG_DiLeu_BaEn_3 | 422 | 428 | PF01217 | 0.502 |
TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.394 |
TRG_ENDOCYTIC_2 | 246 | 249 | PF00928 | 0.393 |
TRG_ENDOCYTIC_2 | 276 | 279 | PF00928 | 0.529 |
TRG_ENDOCYTIC_2 | 337 | 340 | PF00928 | 0.635 |
TRG_ENDOCYTIC_2 | 376 | 379 | PF00928 | 0.257 |
TRG_ENDOCYTIC_2 | 404 | 407 | PF00928 | 0.635 |
TRG_ENDOCYTIC_2 | 414 | 417 | PF00928 | 0.517 |
TRG_ER_diArg_1 | 210 | 213 | PF00400 | 0.671 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S5H6J6 | Leishmania donovani | 68% | 100% |
A0A3S7WRS6 | Leishmania donovani | 47% | 85% |
A4H6N2 | Leishmania braziliensis | 55% | 100% |
A4HV16 | Leishmania infantum | 47% | 85% |
A4HV17 | Leishmania infantum | 64% | 95% |
E9ANQ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 43% | 71% |
E9ANQ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 63% | 94% |
Q4QGX1 | Leishmania major | 70% | 100% |